Arrowhead Pharmaceuticals, Inc. (ARWR)
81.39
-1.00
(-1.21%)
USD |
NASDAQ |
Sep 01, 09:40
Arrowhead Pharmaceuticals Research and Development Expense (Annual) : 585.26M for Sept. 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 585.26M |
| September 30, 2024 | 489.22M |
| September 30, 2023 | 342.31M |
| September 30, 2022 | 288.50M |
| September 30, 2021 | 198.98M |
| September 30, 2020 | 123.54M |
| September 30, 2019 | 76.63M |
| September 30, 2018 | 48.30M |
| September 30, 2017 | 46.25M |
| September 30, 2016 | 41.45M |
| September 30, 2015 | 47.27M |
| September 30, 2014 | 23.14M |
| September 30, 2013 | 8.706M |
| September 30, 2012 | 5.392M |
| Date | Value |
|---|---|
| September 30, 2011 | 3.278M |
| September 30, 2010 | 0.8574M |
| September 30, 2009 | 6.207M |
| September 30, 2008 | 8.310M |
| September 30, 2007 | 10.94M |
| September 30, 2006 | 8.582M |
| September 30, 2005 | 3.793M |
| September 30, 2004 | 0.7934M |
| September 30, 2003 | 0.0034M |
| September 30, 2002 | 0.00 |
| September 30, 2001 | 0.00 |
| September 30, 2000 | 0.00 |
| September 30, 1999 | 0.00 |
| September 30, 1998 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | 1.493B |
| Revolution Medicines, Inc. | 978.68M |
| Moderna, Inc. | 2.917B |
| Intellia Therapeutics, Inc. | 379.09M |
| Denali Therapeutics, Inc. | 418.78M |